| Literature DB >> 31086065 |
Dongqing Cheng1,2, Liang Sun3, Songyan Zou4, Jiang Chen5, Haiyan Mao6, Yanjun Zhang7, Ningbo Liao8,9, Ronghua Zhang10,11.
Abstract
Houttuynia cordata is an herbal plant rich in polysaccharides and with several pharmacological activities. Human noroviruses (HuNoVs) are the most common cause of foodborne viral gastroenteritis throughout the world. In this study, H. cordata polysaccharide (HP), with a molecular weight of ~43 kDa, was purified from H. cordata water extract (HWE). The polysaccharide HP was composed predominantly of galacturonic acid, galactose, glucose, and xylose in a molar ratio of 1.56:1.49:1.26:1.11. Methylation and NMR analyses revealed that HP was a pectin-like acidic polysaccharide mainly consisting of α-1,4-linked GalpA, β-1,4-linked Galp, β-1,4-linked Glcp, and β-1,4-linked Xylp residues. To evaluate the antiviral activity of H. cordata extracts, we compared the anti-norovirus potential of HP with HWE and ethanol extract (HEE) from H. cordata by plaque assay (plaque forming units (PFU)/mL) for murine norovirus-1 (MNV-1), a surrogate of HuNoVs. Viruses at high (8.09 log10 PFU/mL) or low (4.38 log10 PFU/mL) counts were mixed with 100, 250, and 500 μg/mL of HP, HWE or HEE and incubated for 30 min at room temperature. H. cordata polysaccharide (HP) was more effective than HEE in reducing MNV-1 plaque formation, but less effective than HWE. When MNV-1 was treated with 500 μg/mL HP, the infectivity of MNV-1 decreased to an undetectable level. The selectivity indexes of each sample were 1.95 for HEE, 5.74 for HP, and 16.14 for HWE. The results of decimal reduction time and transmission electron microscopic revealed that HP has anti-viral effects by deforming and inflating virus particles, thereby inhibiting the penetration of viruses in target cells. These findings suggest that HP might have potential as an antiviral agent in the treatment of viral diseases.Entities:
Keywords: Houttuynia cordata; antiviral effects; ethanol extract; murine norovirus-1; polysaccharide; water extract
Mesh:
Substances:
Year: 2019 PMID: 31086065 PMCID: PMC6539669 DOI: 10.3390/molecules24091835
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Yields and chemical composition of Houttuynia cordata extracts HP, HWE, and HEE a.
| Composition b | Extract/Fraction | ||
|---|---|---|---|
| HP | HWE | HEE | |
| Extraction yield (%) | 5.73 ± 2.16 | 16.31 ± 1.64 | 9.63 ± 2.31 |
| Total phenolic (μg GAE/mg) | ND c | 14.59 ± 2.41 | 25.42 ± 3.17 |
| Total flavonoid (μg RE/mg) | ND | 10.62 ± 1.43 | 19.76 ± 3.73 |
| Protein (%) | 0.89 ± 0.12 | 2.54 ± 0.12 | 5.68 ± 1.76 |
| Total carbohydrate (%) | 81.12 ± 5.98 | 38.01 ± 3.98 | 2.37 ± 1.45 |
| Neutral sugars (%) | 56.33 ± 4.37 | 26.58 ± 2.54 | 2.37 ± 1.45 |
| Uronic acid (%) | 23.77 ± 3.42 | 12.34 ± 2.13 | ND |
| Molar ratio of monosaccharides d | |||
| GlaUA | 1.56 | 1.37 | ND |
| Gal | 1.49 | 0.94 | ND |
| Rha | 0.83 | ND | ND |
| Ara | 0.68 | ND | ND |
| GluA | 0.31 | ND | ND |
| Glc | 1.26 | 0.31 | ND |
| Man | 0.14 | ND | ND |
| Xyl | 1.11 | ND | ND |
a HP, Houttuynia cordata polysaccharide; HWE, Houttuynia cordata water extract; HEE, Houttuynia cordata ethanol extract. b GAE, gallic acid equivalents; RE, retinol equivalent. c Not detected. d GlaUA, galacturonic acid; Gal, galactose; Rha, rhamnose; Ara, arabinose; GluA, glucuronic acid; Glc, glucose; Man, mannose; Xyl, xylose.
Figure 1FTIR spectra of HP in the frequency range 4000–500 cm−1.
Methylation analysis of Houttuynia cordata polysaccharide HP.
| Sugar a | Partially | Molar Ratio | Linkage d |
|---|---|---|---|
| Gal | 2,3,6-Me3 Gal-6-d2 b | 1.74 | →4)-Gal |
| Gal | 2,3,6-Me3 Gal | 0.93 | →4)-Gal |
| 2,3,4-Me3 Gal | 0.14 | →6)-Gal | |
| 2,3-Me2 Gal | 0.21 | →4,6)-Gal | |
| 2,3,4,6-Me4 Gal | 0.35 | Gal | |
| Glc | 2,3,6-Me3 Glc | 0.95 | →4)-Glc |
| 2,3,4,6-Me4 Glc c | 0.37 | Glc | |
| Xyl | 2,3-Me2 Xyl | 0.84 | →4)-Xyl |
| Rha | 3-Me Rha | 0.22 | →2,4)-Rha |
| Ara | 2,3-Me2 Ara | 0.17 | →5)-Ara |
a GalpA, galactopyranosyluronic acid; Galp, galactopyranose; Glcp, glucopyranose; Xylp, xylopyranose; Rhap, rhamnopyranose; Araf, arabinofuranose; b 2,3,6-Me3Gal-6-d2 = 1,4,5-tri-O-acetyl-6,6-dideutero-2,3,6-tri-O-methyl-galactitol. c 2,3,4,6-Me4-Glc = 1,5-di-O-acetyl-2,3,4,6-tetra-O-methyl-glucitol, etc. d Based on derived O-methylalditol acetates.
Figure 21H (A) and 13C (B) nuclear magnetic resonance (NMR) spectra of HP.
Figure 3The effect of Houttuynia cordata extracts (HP, HCWE, and HCEE) 250, 500, 750, and 1000 μg/mL and phosphate-buffered saline (PBS) control (0 μg/mL) on the viability of the RAW 264.7 cell lines. Numbers are expressed as the % viability of bacteria cells and the murine macrophage cells (RAW 264.7) remaining after 60 min incubation with Houttuynia cordata extracts. A higher number of surviving reflects the concentrations of Houttuynia cordata extracts would not affect the ability to use these host cells to determine anti-viral effects using plaque assays. Each experimental condition was analyzed in triplicate. All data were expressed as mean ± standard deviation. Significant differences with HEE group are designated as * p ≤ 0.05.
Antiviral activities of H. cordata extracts against murine norovirus in RAW 264.7 cells using the mixed treatment assay.
| CC50 (μg/mL) a | EC50 (μg/mL) b | SI c | |
|---|---|---|---|
| HEE | 2132.43 ± 426.17 | 1095.53 ± 113.43 | 1.95 ± 0.84 |
| HWE | 1237.52 ± 367.65 * | 76.75 ± 17.89 * | 16.14 ± 3.81 * |
| HP | 1074.76 ± 187.31 * | 187.24 ± 77.82 * | 5.74 ± 1.96 * |
a CC50: mean (50%) value of cytotoxic concentration. b EC50: mean (50%) value of effective concentration. c SI: selectivity index, CC50/EC50. Each experimental condition was analyzed in triplicate. Values are mean ± standard deviation. Significant differences with HEE group are designated as * p ≤ 0.05.
Effects of HP, HWE, and HEE with low concentrations (4.38 log10 PFU/mL) and high concentrations (8.09 log10 PFU/mL) on mouse norovirus 1 (MNV-1) measured by plaque assay.
| Extracts | Concentration | MNV-1 (log10 PFU/mL) | |||
|---|---|---|---|---|---|
| Low Count (4.38 log10) | High Count (8.09 log10) | ||||
| Recovered Titer c | Reduction e | Recovered Titer | Reduction | ||
| PBS a | 0 μg/mL | 4.38 ± 1.71 | 0 | 8.09 ± 1.95 | 0 |
| 2TU b | 50 μM | 2.50 ± 0.83* | 1.88 | 4.33 ± 2.14 * | 3.76 |
| HP | 100 μg/mL | 3.77 ± 1.04 | 0.61 | 7.49 ± 2.53 | 0.60 |
| 250 μg/mL | 2.62 ± 1.03 * | 1.76 | 6.86 ± 1.81 * | 1.23 | |
| 500 μg/mL | ND* d | 4.38 | 4.61 ± 1.72 * | 3.48 | |
| HWE | 100 μg/mL | 2.51 ± 0.53 * | 1.87 | 6.71 ± 2.12 * | 1.38 |
| 250 μg/mL | ND * | 4.38 | 6.26 ± 1.32 * | 1.83 | |
| 500 μg/mL | ND * | 4.38 | 3.96 ± 0.74 * | 4.12 | |
| HEE | 100 μg/mL | 4.21 ± 0.87 | 0.16 | 8.03 ± 2.89 | 0.06 |
| 250 μg/mL | 3.48 ± 1.33 * | 0.90 | 7.52 ± 1.73 | 0.57 | |
| 500 μg/mL | 3.24 ± 0.41 * | 1.14 | 7.01 ± 2.07 * | 0.98 | |
a,b Phosphate-buffered saline (PBS) was used as untreated control and 2-thiouridine (2TU) as a positive control. c Values are mean ± standard deviation. d Not detected. e Each titer was subtracted from the titer of the untreated sample (PBS). Each experimental condition was analyzed in triplicate. Significant differences with untreated control group are designated as * p ≤ 0.05.
Figure 4Change of MNV-1 titers versus incubation time after exposure to HP, HWE or HEE. Two-hundred-and-fifty (μg/mL) of HP, HWE or HEE solutions were added to an equal volume of MNV-1 at titer of ~8 log10 PFU/mL and incubated for up to 60 min at room temperature. The MNV-1 was recovered at 0, 10, 20, 30, 40, 50, and 60 min and assayed for its infectivity using standardized plaque assay. Each experimental condition was analyzed in triplicate. All data were expressed as mean ± standard deviation. Significant differences with control group are designated as * p ≤ 0.05.
The Effect of HP with different concentrations on the D-values of MNV-1.
| HP (μg/mL) | Weibull Model Parameters a | ||||
|---|---|---|---|---|---|
| α ± SD | RMSE | R2 | |||
| 100 | 0.144 ± 0.65 | 0.581 ± 0.04 | 28.098 ± 2.44 | 0.03 | 0.97 |
| 250 | 0.213 ± 0.01 | 0.817 ± 0.26 | 6.647 ± 0.93 | 0.02 | 0.98 |
| 500 | 0.866 ± 0.08 | 0.308 ± 0.04 | 1.597 ± 0.31 | 0.04 | 0.95 |
aK is the characteristic time (h); α = shape parameter; D-value = storage time (day) required to reduce MNV-1 or Escherichia coli by 90%; RMSE = correlation coefficient, a lower RMSE value indicates a better fit to the data; R2 = correlation coefficient, a higher R2 value indicate a better fit to the data. b Values are mean ± standard deviation. Each experimental condition was analyzed in triplicate.
Figure 5Transmission electron microscopic (TEM) images of MNV-1 in the absence or presence of HP. MNV-1 control (A) and MNV-1 treated with 250 μg/mL HP (B). Scale bars, 100 nm.